FdaApplication
NDA 213586
Identifiers
- fda_app_no: NDA213586
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA NEUROSCIENCE INC |
| application_type | NDA |
| approval_date | 2023-04-28 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| UZEDY | RISPERIDONE | 200MG/0.56ML (200MG/0.56ML) | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
| UZEDY | RISPERIDONE | 125MG/0.35ML (125MG/0.35ML) | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
| UZEDY | RISPERIDONE | 50MG/0.14ML (50MG/0.14ML) | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
| UZEDY | RISPERIDONE | 150MG/0.42ML (150MG/0.42ML) | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
| UZEDY | RISPERIDONE | 75MG/0.21ML (75MG/0.21ML) | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
| UZEDY | RISPERIDONE | 100MG/0.28ML (100MG/0.28ML) | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
| UZEDY | RISPERIDONE | 250MG/0.7ML (250MG/0.7ML) | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
7 products